Silevertinib, Black Diamond Therapeutics' lead asset, showed strong Phase 2 results with 60% ORR and 86% CNS ORR. Read why ...
TG Therapeutics, Inc. (NASDAQ: TGTX) today announced the initiation of a Phase 2 clinical trial evaluating BRIUMVI® (ublituximab-xiiy), in adults with treatment-resistant schizophrenia. The Phase 2 ...
A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...
Discusses Phase II Acute Graft Versus Host Disease and Phase III Osteoarthritis Trial Results June 21, 2026 6:30 ...
When Is the Right Time? A Qualitative Study of Timing of Specialty Palliative Care in Patients With Brain Tumors Phase II trials are intended to identify promising treatment paradigms for definitive ...
The Department of War (DoW) is advancing its push to equip ground combat forces with low-cost, scalable one-way attack (OWA) small unmanned aerial systems (sUAS). The department has released the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results